Shuttle Pharmaceuticals Holdings (SHPH) Enterprise Value (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Enterprise Value history runs 6 years deep, the most recent figure standing at -$1.1 million for Q1 2026.

• In Q1 2026, Enterprise Value rose 76.44% year-over-year to -$1.1 million; the TTM figure through Mar 2026 stood at -$1.1 million (up 76.44% YoY), while the FY2025 annual figure was -$257955.0, up 86.57% from the prior year.
• Enterprise Value was -$1.1 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from -$257955.0 in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$156656.0 in Q3 2024 to a low of -$9.1 million in Q3 2022.
• Historically, Enterprise Value has averaged -$4.4 million across 5 years, with a median of -$4.5 million in 2025.
• The sharpest annual moves came in 2022 and 2024: Enterprise Value tumbled 6191.01% in 2022, then soared 97.7% in 2024.
• A 5-year view of Enterprise Value shows it stood at -$5.4 million in 2022, then retreated by 6.71% to -$5.8 million in 2023, then surged by 66.75% to -$1.9 million in 2024, then soared by 86.57% to -$257955.0 in 2025, then sank by 312.0% to -$1.1 million in 2026.
• The last three Enterprise Value figures came in at -$1.1 million (Q1 2026), -$257955.0 (Q4 2025), and -$2.1 million (Q3 2025), per Business Quant data.